{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-116942","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.415691+00:00","generated_at":"2026-05-30T02:03:52.121183+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Elanco appoints Stacey Ma to board; board expands to 15 members","bullets":["Ma appointed effective Nov 11, 2024; board increased from 14 to 15 directors.","Ma will serve on Innovation, Science and Technology Committee.","Ma is EVP of Pharmaceutical Development and Manufacturing at Gilead Sciences.","Her expertise in CMC and drug development supports Elanco's IPP strategy.","No related party transactions or arrangements in her appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-116942","json":"https://secwatch.observer/filing/0001104659-24-116942.json","markdown":"https://secwatch.observer/filing/0001104659-24-116942.md","text":"https://secwatch.observer/filing/0001104659-24-116942.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000110465924116942/0001104659-24-116942-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000110465924116942/tm2428235d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:03:52.121183+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bda925e8b1","claim":"Stacey Ma was appointed as Director at Elanco Animal Health Inc.","evidence_excerpt":"On November 11, 2024, the Board of Directors (the “Board”) of Elanco Animal Health Incorporated (the “Company”) appointed Stacey Ma, PhD, to the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739104/000110465924116942/0001104659-24-116942-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}